The Evolution of Drug Design and Its Impact on Bioanalysis (Part 2)

In this 58th episode of "The Weekly Bioanalysis" podcast, Dom and John wrap up their 2-part series on the Evolution of Bioanalysis, as they dive into the history of their bioanalysis careers by reviewing Drug Design and Development, and how that has effected the things CROs like KCAS do today. They discuss where the pharmaceutical and biopharmaceutical industry has been, and work their from 2010 or so to the modern day lab space - and even a bit on what the future may hold in the space.

"The Weekly Bioanalysis" is a podcast dedicated to discussing Bioanalytical news, tools and services related to the Pharmaceutical, Biopharmaceutical and Biomarker industries. Every month, KCAS will bring you another 60 minutes (or so) of friendly banter between our two finest Senior Scientific Advisors as they chat over coffee and discuss what they've learned about the Bioanalytical world the past couple of weeks. The Weekly Bioanalysis is brought to you by KCAS.

KCAS is a progressive growing contract research organization of well over 250 talented and dedicated individuals with growing operations in Kansas City, Doylestown, PA and Milan, Italy, where we are committed to serving our clients and improving health worldwide. Our experienced scientists provide stand-alone bioanalytical services to the Pharmaceutical, Biopharmaceutical, Animal Health and Medical Device industries.